Huron's life science practice comprises strategy and access (formerly known as Pope Woodhead), and is part of a continuum of offerings that supports the development and commercialization of pharmaceutical products and services.
The pace of change in the pharmaceutical landscape demands innovative solutions from all industry stakeholders. At Huron we typically work with life science companies that need to deal with issues such as:
- Achieving affordable access to products while managing uncertainty around the underlying data
- Harnessing the power of new technologies, including digital technologies for building capabilities in real-world data and analytics, targeted design, companion diagnostics and more
- Developing new innovative business models that include building the patient’s voice into decision making
- Playing an active role in shaping regulatory and policy agendas for the future
Discover how Huron can help you to harness new developments and stay ahead of the curve.